AAAAAA
Results: 1-25/33
Authors:
Ong, J
Younossi, ZM
Reddy, V
Price, LL
Gramlich, T
Mayes, J
Boparai, N
Citation: J. Ong et al., Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease, LIVER TRANS, 7(9), 2001, pp. 797-801
Authors:
Falck-Ytter, Y
Younossi, ZM
Marchesini, G
McCullough, AJ
Citation: Y. Falck-ytter et al., Clinical features and natural history of nonalcoholic steatosis syndromes, SEM LIV DIS, 21(1), 2001, pp. 17-26
Authors:
Hadziyannis, E
Hadziyannis, A
Yen-Lieberman, B
Kiwi, ML
Hodnick, S
Spanou, F
Starkey, C
Younossi, ZM
Citation: E. Hadziyannis et al., Hepatitis C virus RNA assays - A comparison of SuperQuant and Monitor, J CLIN GAST, 33(1), 2001, pp. 45-48
Authors:
Younossi, ZM
Mullen, KD
Zakko, W
Hodnick, S
Brand, E
Barnes, DS
Carey, WD
McCullough, AC
Easley, K
Boparai, N
Gramlich, T
Citation: Zm. Younossi et al., A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy, J HEPATOL, 34(1), 2001, pp. 128-133
Authors:
Ong, JP
Younossi, ZM
Speer, C
Olano, A
Gramlich, T
Boparai, N
Citation: Jp. Ong et al., Chronic hepatitis C and superimposed nonalcoholic fatty liver disease, LIVER, 21(4), 2001, pp. 266-271
Authors:
Ong, JP
Younossi, ZM
Gramlich, T
Goodman, Z
Mayes, J
Sarbah, S
Yen-Lieberman, B
Citation: Jp. Ong et al., Interferon alpha 2B and ribavirin in severe recurrent cholestatic hepatitis C, TRANSPLANT, 71(10), 2001, pp. 1486-1488
Authors:
Younossi, ZM
Citation: Zm. Younossi, Chronic liver disease and health-related quality of life, GASTROENTY, 120(1), 2001, pp. 305-307
Authors:
Aggarwal, A
Ong, JP
Younossi, ZM
Nelson, DR
Hoffman-Hogg, L
Arroliga, AC
Citation: A. Aggarwal et al., Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU, CHEST, 119(5), 2001, pp. 1489-1497
Authors:
Shen, B
Younossi, ZM
Dolmatch, B
Newman, JS
Henderson, JM
Ong, JP
Gramlich, T
Yamani, M
Citation: B. Shen et al., Patent ductus venosus in an adult presenting as pulmonary hypertension, right-sided heart failure, and portosystemic encephalopathy, AM J MED, 110(8), 2001, pp. 657-660
Authors:
Mendez, P
Saeian, K
Reddy, KR
Younossi, ZM
Kerdel, F
Badalamenti, S
Jeffers, LJ
Schiff, ER
Citation: P. Mendez et al., Hepatitis C, cryoglobulinemia, and cutaneous vasculitis associated with unusual and serious manifestations, AM J GASTRO, 96(8), 2001, pp. 2489-2493
Authors:
Younossi, ZM
Boparai, N
Price, LL
Kiwi, ML
McCormick, M
Guyatt, G
Citation: Zm. Younossi et al., Health-related quality of life in chronic liver disease: The impact of type and severity of disease, AM J GASTRO, 96(7), 2001, pp. 2199-2205
Authors:
Younossi, ZM
Boparai, N
McCormick, M
Price, LL
Guyatt, G
Citation: Zm. Younossi et al., Assessment of utilities and health-related quality of life in patients with chronic liver disease, AM J GASTRO, 96(2), 2001, pp. 579-583
Authors:
Broussard, CN
Aggarwal, A
Lacey, SR
Post, AB
Gramlich, T
Henderson, JM
Younossi, ZM
Citation: Cn. Broussard et al., Mushroom poisoning - From diarrhea to liver transplantation, AM J GASTRO, 96(11), 2001, pp. 3193-3196
Authors:
Younossi, ZM
McCormick, M
Price, LL
Boparai, N
Farquhar, L
Henderson, JM
Guyatt, G
Citation: Zm. Younossi et al., Impact of liver transplantation on health-related quality of life, LIVER TRANS, 6(6), 2000, pp. 779-783
Authors:
Saadeh, S
Younossi, ZM
Citation: S. Saadeh et Zm. Younossi, The spectrum of nonalcoholic fatty liver disease: From steatosis to nonalcoholic steatohepatitis, CLEV CLIN J, 67(2), 2000, pp. 96
Authors:
Younossi, ZM
Citation: Zm. Younossi, Viral hepatitis guide for practicing physicians, CLEV CLIN J, 67, 2000, pp. 6-45
Authors:
Zdilar, D
Franco-Bronson, K
Buchler, N
Locala, JA
Younossi, ZM
Citation: D. Zdilar et al., Hepatitis C, interferon alfa, and depression, HEPATOLOGY, 31(6), 2000, pp. 1207-1211
Authors:
Younossi, ZM
Singer, ME
McHutchison, JG
Shermock, KM
Citation: Zm. Younossi et al., Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment ofchronic hepatitis C - Reply, HEPATOLOGY, 31(3), 2000, pp. 807-808
Authors:
Duchini, A
Younossi, ZM
Saven, A
Bordin, GM
Knowles, HJ
Pockros, PJ
Citation: A. Duchini et al., An open-label pilot trial of cladibrine (2-chlorodeoxyadenosine) in patients with primary sclerosing cholangitis, J CLIN GAST, 31(4), 2000, pp. 292-296
Authors:
Sarbah, SA
Younossi, ZM
Citation: Sa. Sarbah et Zm. Younossi, Hepatitis C: An update on the silent epidemic (vol 31, pg 125, 2000), J CLIN GAST, 31(1), 2000, pp. 79-79
Authors:
Sarbah, SA
Younossi, ZM
Citation: Sa. Sarbah et Zm. Younossi, Hepatitis C - An update on the silent epidemic, J CLIN GAST, 30(2), 2000, pp. 125-143
Authors:
Ong, JP
Sands, M
Younossi, ZM
Citation: Jp. Ong et al., Transjugular intrahepatic portosystemic shunts (TIPS) - A decade later, J CLIN GAST, 30(1), 2000, pp. 14-28
Authors:
Younossi, ZM
Kiwi, ML
Boparai, N
Price, LL
Guyatt, G
Citation: Zm. Younossi et al., Cholestatic liver diseases and health-related quality of life, AM J GASTRO, 95(2), 2000, pp. 497-502
Authors:
Matteoni, CA
Younossi, ZM
Citation: Ca. Matteoni et Zm. Younossi, Q: In diagnosing hepatitis C, which patient needs which test?, CLEV CLIN J, 66(9), 1999, pp. 529-530
Authors:
Younossi, ZM
Perrillo, RP
Citation: Zm. Younossi et Rp. Perrillo, The roles of amantadine, rimantadine, ursodeoxycholic acid, and NSAIDs, alone or in combination with alpha interferons, in the treatment of chronic hepatitis C, SEM LIV DIS, 19, 1999, pp. 95-102